Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 66   

Articles published

PFE 34.38 +0.12 (0.35%)
price chart
Merck, Pfizer Back Lawmakers Who Oppose Company Products
The drug industry has many concerns in Washington besides contraception, including proposals to allow drugs to be imported from Canada and enabling the federal government to negotiate lower prices for Medicare recipients.
Goodbye, Lipitor. Pfizer Bids a Farewell
Pfizer officials told The Wall Street Journal that the company is no longer negotiating new contracts to sell Lipitor to health plans, which are signing up to sell generic versions at far lower prices.
FDA Recommendations Bode Well For Pfizer
Pfizer (NYSE:PFE) is still transitioning itself after its best selling drug Lipitor went off patent in 2011. Also starting in July a marketing partnership between Amgen and Pfizer ends which will result in a large loss of revenue from the blockbuster ...
Pfizer's Arthritis Pill Raises Safety Concerns, FDA Staff Says  Bloomberg
Pfizer Gets Support For Arthritis Drug Approval  ValueWalk
Pfizer, BYU settle Celebrex lawsuit for $450M
One month from the scheduled beginning of a complex eight-week trial, Brigham Young University and drug giant Pfizer Inc. settled a lawsuit Tuesday for $450 million over whether the Utah school had been cheated out of billions of dollars in royalties ...
Pfizer says on lookout for mid-size drug deals  Reuters
Dow Chemical taking Pfizer space
COLLEGEVILLE —Dow Chemical Co. has finalized a long-term lease on 800,000 square feet of space at Pfizer Inc.'s campus here in what is one of the largest lease deals to be struck in the suburban office market.
Pfizer, Teva Reach Licensing Deal For Generic Zyvox
Law360, New York (May 31, 2012, 4:15 PM ET) -- Pfizer Inc. and Teva Pharmaceutical Industries Ltd. have reached an agreement on a licensing deal for a generic version of Pfizer's antibiotic Zyvox, according to a settlement affirmed by a Delaware ...
Amylin Said to Attract Interest From Pfizer, AstraZeneca
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter.
Merck's Frazier Says He Won't Follow Pfizer in Splitting Company
May 31 (Bloomberg) -- Merck & Co. Chief Executive Officer Ken Frazier said he doesn't plan on breaking up the company by splitting off businesses the way Pfizer Inc. and Abbott Laboratories are doing. “My philosophy is fix what is broke, don't do the ...
Pfizer recalls Advil bottles from distributors
BOSTON (MarketWatch) -- Pfizer Inc. PFE, -1.50% has recalled about 650,000 bottles of its popular Advil Liqui-Gel pain reliever from its retail-distribution centers over concerns that they carry an unusual odor, The Wall Street Journal reported Friday ...
Pfizer Reports Subpar Lyrica Phase 3 Results
Pfizer Inc. announced that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint.